MetaADEDB 2.0 @ LMMD
Codeine sulfate anhydrous
(BCXHDORHMMZBBZ-DORFAMGDSA-N)
Structure
SMILES
OS(=O)(=O)O.COc1ccc2c3c1O[C@@H]1[C@@]43CCN([C@H](C2)[C@@H]4C=C[C@@H]1O)C.COc1ccc2c3c1O[C@@H]1[C@@]43CCN([C@H](C2)[C@@H]4C=C[C@@H]1O)C
Molecular Formula:
C36H44N2O10S
Molecular Weight:
696.807
Log P:
3.3060
Hydrogen Bond Acceptor:
12
Hydrogen Bond Donor:
4
TPSA:
166.84
CAS Number(s):
1420-53-7
Synonym(s)
1.
Codeine sulfate anhydrous
External Link(s)
PubChem Compound5359613
Adverse Drug Event(s)
NameNumber of ReportsReference(s)Data Source
1NauseaFAERS: 68US FAERS
2VomitingFAERS: 57US FAERS
3PruritusFAERS: 36US FAERS
4Abdominal discomfortFAERS: 27US FAERS
5MalaiseFAERS: 18US FAERS
6UrticariaFAERS: 15US FAERS
7DizzinessFAERS: 13US FAERS
8Drug ineffectiveFAERS: 13US FAERS
9HypersensitivityFAERS: 13US FAERS
10Product quality issueFAERS: 10US FAERS
11HeadacheFAERS: 9US FAERS
12Toxicity to various agentsFAERS: 9US FAERS
13NervousnessFAERS: 5US FAERS
14ErythemaFAERS: 4US FAERS
15Respiratory DepressionFAERS: 4US FAERS
16AnxietyFAERS: 3US FAERS
17AstheniaFAERS: 3US FAERS
18Depressed Level of ConsciousnessFAERS: 3US FAERS
19Respiratory arrestFAERS: 3US FAERS
20SomnolenceFAERS: 3US FAERS
21Activities of daily living impairedFAERS: 2US FAERS
22BronchopneumoniaFAERS: 2US FAERS
23Completed SuicideFAERS: 2US FAERS
24ConstipationFAERS: 2US FAERS
25Drug abuseFAERS: 2US FAERS
26Feeling abnormalFAERS: 2US FAERS
27FormicationFAERS: 2US FAERS
28OverdoseFAERS: 2US FAERS
29PainFAERS: 2US FAERS
30Unevaluable eventFAERS: 2US FAERS
31Abdominal PainFAERS: 1US FAERS
32Accidental underdoseFAERS: 1US FAERS
33Acute myocardial infarctionFAERS: 1US FAERS
34AgitationFAERS: 1US FAERS
35Analgesic drug level above therapeuticFAERS: 1US FAERS
36Anaphylactic shockFAERS: 1US FAERS
37Anaphylactoid ReactionFAERS: 1US FAERS
38Anion GapFAERS: 1US FAERS
39AsthmaFAERS: 1US FAERS
40BradycardiaFAERS: 1US FAERS
41Chest PainFAERS: 1US FAERS
42Chest discomfortFAERS: 1US FAERS
43DyspepsiaFAERS: 1US FAERS
44Euphoric moodFAERS: 1US FAERS
45Feeling jitteryFAERS: 1US FAERS
46Gastrointestinal PainFAERS: 1US FAERS
47HypersomniaFAERS: 1US FAERS
48HypotensionFAERS: 1US FAERS
49Incorrect dose administeredFAERS: 1US FAERS
50Infectious peritonitisFAERS: 1US FAERS
51LethargyFAERS: 1US FAERS
52Mental impairmentFAERS: 1US FAERS
53Mental status changesFAERS: 1US FAERS
54Metabolic acidosisFAERS: 1US FAERS
55Multiple allergiesFAERS: 1US FAERS
56Non-cardiac chest painFAERS: 1US FAERS
57ParanoiaFAERS: 1US FAERS
58PoisoningFAERS: 1US FAERS
59Product tamperingFAERS: 1US FAERS
60Respiratory distressFAERS: 1US FAERS
61RetchingFAERS: 1US FAERS
62ScreamingFAERS: 1US FAERS
63SwellingFAERS: 1US FAERS
64SyncopeFAERS: 1US FAERS
65TremorFAERS: 1US FAERS
66Visual ImpairmentFAERS: 1US FAERS
67WheezingFAERS: 1US FAERS
68muscle injuryFAERS: 1US FAERS
Powered by :

Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120240

Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.